Olaratumab

LARTRUVO 10 mg/ml Concentrate For Solution For Infusion

Saudi ArabiaAuthorised

This entry comes from a historical list and may no longer be current.

In other countries

The same active substances on other registers, the same brand first.

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Olaratumab

LARTRUVO 10 mg/ml Concentrate For Solution For Infusion

Saudi ArabiaAuthorised

Ask Osler about it

This entry comes from a historical list and may no longer be current.

In other countries

The same active substances on other registers, the same brand first.

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pack	Code	Status
50 ml

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Saudi Food and Drug Authority

Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.

Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Olaratumab
Register: Saudi Arabia (SFDA)
Status: Authorised
Status in the register: Listed by SFDA (2023 file)
Manufacturer: Eli Lilly
Manufacturer: ELI LILLY, United States
Procedure: Foreign manufacture
Supply: Prescription
Biological medicine: Yes